
Core Laboratories Inc.: updates and filings
Price
$8.38
November 18, 2026Market cap $386M
What Ploutos Investor adds for Core Laboratories
Part of Ploutos Investor, €9.99 a month
- The full history: 5 fiscal years, from 2021
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 28, 2026next Jan 28, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
May 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 30, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 28, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 25, 2026Officer or director changeForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Results of operations, Regulation FD disclosureForm8-K
- Jun 29, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Conflict minerals reportFormSD
- May 13, 2026Shareholder voteForm8-K
- May 1, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 29, 2026Results of operations, Regulation FD disclosureForm8-K
- Mar 31, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Mar 31, 2026Additional annual meeting materialFormDEFA14A
- Mar 31, 2026Annual meeting proxy statementFormDEF 14A
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 23, 2026Regulation FD disclosureForm8-K
- Mar 23, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 17, 2026Results of operations (amendment)Form8-K/A
- Mar 5, 2026Amended articles or bylawsForm8-K
- Mar 3, 2026Notice that the annual report will be filed lateFormNT 10-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 30, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 28, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 25, 2026 | 8-K | Officer or director change | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 30, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jun 29, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SD | Conflict minerals report | Document |
| May 13, 2026 | 8-K | Shareholder vote | Document |
| May 1, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 29, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Mar 31, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Mar 31, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 31, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 23, 2026 | 8-K | Regulation FD disclosure | Document |
| Mar 23, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 17, 2026 | 8-K/A | Results of operations (amendment) | Document |
| Mar 5, 2026 | 8-K | Amended articles or bylaws | Document |
| Mar 3, 2026 | NT 10-K | Notice that the annual report will be filed late | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 17, 2023.
The full analysis
What do Core Laboratories's filings show?
The filings are where every one of Core Laboratories's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.